ARCA Biopharma Announces Enrollment in Phase 2B Clinical Trial for COVID Treatment

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • 04/05/2021 at 3:04 pm #12567

    Deprecated: Function seems_utf8 is deprecated since version 6.9.0! Use wp_is_valid_utf8() instead. in /home/cobioscience/www/www/wp-includes/functions.php on line 6131

    Deprecated: Function seems_utf8 is deprecated since version 6.9.0! Use wp_is_valid_utf8() instead. in /home/cobioscience/www/www/wp-includes/functions.php on line 6131
    Colorado BioScience AssocationColorado BioScience Association
    Keymaster

    The company is actively enrolling patients in the trial, evaluating rNAPc2 as a potential treatment for COVID-19 patients who are at high risk for thrombotic complications.

    More Information

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.